Shashikant Kulkarni
Chief Tech/Sci/R&D Officer at NEOGENOMICS, INC.
Net worth: 976 165 $ as of 2024-03-30
Profile
Shashikant Kulkarni is currently the Chief Scientific Officer & Executive VP-Research at NeoGenomics, Inc. He previously worked as the Chief Scientific Officer & SVP-Innovation at Baylor Miraca Genetics Laboratories LLC.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NEOGENOMICS, INC.
0.05% | 2023-03-31 | 62,097 ( 0.05% ) | 976 165 $ | 2024-03-30 |
Shashikant Kulkarni active positions
Companies | Position | Start |
---|---|---|
NEOGENOMICS, INC. | Chief Tech/Sci/R&D Officer | 2022-03-06 |
Former positions of Shashikant Kulkarni
Companies | Position | End |
---|---|---|
Baylor Miraca Genetics Laboratories LLC
Baylor Miraca Genetics Laboratories LLC Medical/Nursing ServicesHealth Services Part of H.U. Group Holdings, Inc., Baylor Miraca Genetics Laboratories LLC is a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, including whole genome sequencing, whole exome sequencing, and focused panels. The private company is based in Houston, TX, located in the Texas Medical Center, and serves clients in 50 states and 16 countries. Baylor Genetics specializes in clinically relevant genetic testing and helps determine an individual’s chance of developing or passing on a genetic disorder. Baylor Genetics excels in the field of genetics and precision medicine. Baylor Miraca Genetics Laboratories was acquired by Miraca USA, Inc. from Baylor College of Medicine on February 02, 2015 for $138 million. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEOGENOMICS, INC. | Health Services |
Private companies | 1 |
---|---|
Baylor Miraca Genetics Laboratories LLC
Baylor Miraca Genetics Laboratories LLC Medical/Nursing ServicesHealth Services Part of H.U. Group Holdings, Inc., Baylor Miraca Genetics Laboratories LLC is a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, including whole genome sequencing, whole exome sequencing, and focused panels. The private company is based in Houston, TX, located in the Texas Medical Center, and serves clients in 50 states and 16 countries. Baylor Genetics specializes in clinically relevant genetic testing and helps determine an individual’s chance of developing or passing on a genetic disorder. Baylor Genetics excels in the field of genetics and precision medicine. Baylor Miraca Genetics Laboratories was acquired by Miraca USA, Inc. from Baylor College of Medicine on February 02, 2015 for $138 million. | Health Services |
- Stock Market
- Insiders
- Shashikant Kulkarni